<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347606">
  <stage>Registered</stage>
  <submitdate>20/10/2011</submitdate>
  <approvaldate>24/10/2011</approvaldate>
  <actrnumber>ACTRN12611001105932</actrnumber>
  <trial_identification>
    <studytitle>Determination of the Impact of Different Cereals on Mineral Status</studytitle>
    <scientifictitle>Determination of the Impact of Cereal Consumption on Mineral Status in Postmenopausal Women</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>normal mineral bioavailability</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>We will be testing 4 cereals that differ in their nutrient composition. The 4 cereal types will deliver 1. high, 2. moderate-high, 3. moderate or 4. low (negative control) levels of dietary fibre. For the study duration participants will follow their habitual dietary pattern with some restrictions to ensure it is low in fibre. This is a parallel study design, with participants randomised to one of four groups. Participants will be asked to consume 100g of the test food daily for an 8 week testing period. At baseline participants will undergo a DXA total body, forearm and lumbar spine scan. Each fortnight participants will attend the clinic for a fasted blood sample and to complete 2 short questionnaires (product consumption checklist and 3 day food diary) and prior to the visit collect a 48 hour urine. At week 8 participants will undergo a dual stable isotope test.</interventions>
    <comparator>refined cereal - low fibre negative control</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>calcium absorption - dual stable isotope laboratory analysis</outcome>
      <timepoint>week 8</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>mineral balance - urine laboratory analysis</outcome>
      <timepoint>baseline, week 2, 4, 6, 8</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>DXA scan for bone mineral density</outcome>
      <timepoint>baseline</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>calcium and bone biomarkers - laboratory blood analysis</outcome>
      <timepoint>baseline, week 2, 4, 6, 8</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>female, aged &lt;75 years, postmenopausal &gt;6years and not undergoing hormone replacement therapy.
Not on vitamin or mineral supplements or unwilling to abstain for the duration of the study.
Not received any medication that in the opinion of the investigator could interfere with the study and no medications likely to modulate gut and/or metabolic function.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Bone mineral density in the osteoporotic density range.
Intolerance to lactose.
Use of any form of drug therapy or medication or supplements that may interfere with bowel or bone function (such as antibiotics, laxatives, osteoporotic treatments etc).
Known or suspected personal history or family history of adverse events, hypersensitivity or intolerance to consumption plant-based foods which will be tested in this study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence>stratified block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2012</anticipatedstartdate>
    <actualstartdate>1/03/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/05/2012</actualenddate>
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>CSIRO Food Futures National Research Flagship</primarysponsorname>
    <primarysponsoraddress>PO Box 10041
Adelaide SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>CSIRO Food Futures National Research Flagship</fundingname>
      <fundingaddress>PO Box 10041
Adelaide SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will assess whether cereals can improve mineral bioavailability in postmenopausal women.</summary>
    <trialwebsite />
    <publication>N/A to date</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CFNS Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 10041
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>29/02/2012</ethicapprovaldate>
      <hrec>CFNS HREC 11/15</hrec>
      <ethicsubmitdate>21/10/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Tony Bird</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide SA 5000</address>
      <phone>+61 8 8303 8902</phone>
      <fax>+61 8 8303 8899</fax>
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Tony Bird</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide SA 5000</address>
      <phone>+61 8 8303 8902</phone>
      <fax>+61 8 8303 8899</fax>
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Bianca Benassi-Evans</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide SA 5000</address>
      <phone>+61 8 83038982</phone>
      <fax>+61 8 83038899</fax>
      <email>bianca.benassi@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Tony Bird</name>
      <address>CSIRO Food and Nutritional Sciences PO Box 10041 Adelaide SA 5000 </address>
      <phone>+61 8 8303 8902</phone>
      <fax />
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>